Skip to content

A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD

A Multicenter Prospective Randomized Controlled Study of Robot Pancreaticoduodenectomy Versus Laparoscopic Pancreaticoduodenectomy

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05755607
Enrollment
200
Registered
2023-03-06
Start date
2023-06-01
Completion date
2031-07-01
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common Bile Duct Diseases, Pancreatic Cancer, Periampullary Carcinoma

Keywords

Robot pancreaticoduodenectomy, laparoscopic pancreaticoduodenectomy, randomized controlled trial, Safety and Efficacy

Brief summary

laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancreaticoduodenectomy(OPD) in terms of reducing surgical trauma and hospitalization time, but there are few studies on their perioperative safety and prognostic effects.However, there are few studies on the perioperative safety and prognostic effects of both procedures. In this trial, the perioperative data and prognosis of both procedures were collected and analyzed through a prospective, multicenter approach to investigate the advantages and disadvantages of both procedures.

Detailed description

In this trial, subjects proposed for PD were randomly divided into two groups, LPD and RPD, according to inclusion and exclusion criteria. Patients in both groups were operated and received perioperative management under the same surgical team and were operated according to the standard PD surgical approach. Subsequently, perioperative clinical data and long-term prognostic data of subjects in both groups will be collected and statistically analyzed to explore a better surgical approach.

Interventions

The laparoscopic group will perform the surgical procedure using laparoscopic instruments, with three surgeons involved throughout the procedure.

PROCEDURERobot Pancreaticoduodenectomy

The robotic team will perform the surgery using the latest generation Da Vinci robotic surgical system, with an additional surgeon assisting in the procedure.

Sponsors

The First Affiliated Hospital of University of South China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The way of surgery.

Intervention model description

The key difference in treatment between the two groups is the surgical approach, with the LPD group undergoing laparoscopic-assisted pancreaticoduodenectomy and the RPD group undergoing robotic-assisted pancreaticoduodenectomy, with all treatments remaining the same except for the surgical approach.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years old * Preoperative imaging suggested the presence of space occupying in the head of the pancreas, ampullary abdomen, and distal common bile duct tumor lesions to be treated with Pancreaticoduodenectomy * No distant transfer * No significant vascular invasion was received

Exclusion criteria

* With tumors of other organs * Patients unable to tolerate anesthesia and operation due to serious abnormalities in functions of heart, lung and other important organs * Patients found intraoperative peripheral organ metastasis combined with excision of other organs or found intraoperative radical excision could not be performed and underwent palliative drainage surgery or end the surgery * Preoperative adjuvant therapy was given

Design outcomes

Primary

MeasureTime frameDescription
Rate of long-term Survival3 yearsSurvival will be documented 3 years after surgery

Secondary

MeasureTime frameDescription
Unplanned re-admission rate after discharge within 30 days3 monthsSerious discomfort requiring re-admission within 30 days after discharge will be recorded, and the safety of the surgical method will be evaluated by this indicator
Incidence of postoperative complications2 monthsDuring hospitalization, common complications of pancreaticoduodenectomy, such as postoperative pancreatic fistula, bile leak, gastrojejunostomy leak, and delayed gastric emptying, will be recorded according to the international diagnostic criteria to evaluate the short-term safety of this surgical approach

Contacts

Primary ContactGuodong Chen, PhD
Chenguodong@usc.edu.cn(+86)15211450345
Backup ContactDanjun Chen, PhD
nhfykyb@163.com(+86)13789353900

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026